MedTrace Logo

Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients

NCT05673798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 569

Last updated 2023-01-10

No results posted yet for this study

Summary

In this retrospective study, patients diagnosed with SCLC between January 2011 to September 2022 were identified from database of the Second Hospital of Shandong University. Following inclusion criteria should be met: (1) Had histologically or cytologically confirmed newly diagnosed SCLC; (2) No cancer treatment has been done before; (3) Complete clinical, laboratory, imaging, treatment data and follow-up information. The exclusion criteria included: Patients without complete records for pathological information, complete epidemiology and other key clinical information.

Conditions

Interventions

OTHER

initial chemotherapy response

Initial chemotherapy response is the first imaging examination of SCLC patient after starting chemotherapy

Sponsors & Collaborators

  • The Second Hospital of Shandong University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2022-11-30
Completion
2022-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05673798 on ClinicalTrials.gov